2025 Connective Tissue Oncology Society
The Synovial Sarcoma Foundation is excited to share that we are on site this week at the 2025 Connective Tissue Oncology Society…
Rise in Early-Onset Cancers: More Diagnoses, Not Always More Disease
Not every detected cancer is clinically meaningful. For younger patients, especially, this can mean confronting a diagnosis that may never…
Dr. Theodore W. Laetsch, Synovial Sarcoma Foundation Board Member, Receives $1 Million Grant to Advance Rare Tumor Studies
The Synovial Sarcoma Foundation is pleased to highlight a significant milestone at the Children’s Hospital of Philadelphia (CHOP), where pediatric…
Innovative Approach Shows Promise Against Synovial Sarcoma Using Protein-Blocking Drugs
The Synovial Sarcoma Foundation is dedicated to supporting cutting-edge research that advances treatment options for this rare and aggressive cancer.…
New Market Insights Highlight Growth in Synovial Sarcoma Treatments
The Synovial Sarcoma Foundation is committed to staying informed on the latest research and developments in this rare and aggressive…
Tumor Board Continues to Grow with New Members to Advance Breakthrough Treatments for Synovial Sarcoma Patients
We are proud to share that the Tumor Board now includes 42 participating institutions, strengthening our collective expertise and reach.…
Synovial Sarcoma Foundation Celebrates Groundbreaking Achievement by Rachel Dr. Hurly
The Synovial Sarcoma Foundation is proud to announce a significant milestone in pediatric cancer research: Dr. Rachel Hurly, a dedicated…
Callan Spence: Survivor. Driver. Relentless Advocate.
Callan Spence isn’t waiting for progress—he’s chasing it down at full speed. At 20 years old, Callan is already a…
Inaugural Synovial Sarcoma Conference
On March 1, CHOP, in collaboration with Penn Medicine and the Synovial Sarcoma Foundation, hosted the first-ever national virtual conference…